TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

PROVISION OF LONG ACTING REVERSIBLE CONTRACEPTION (LARCS) IN PRIMARY CARE

General-practitioner services
Health services
West Midlands (UKG2)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Midlands Partnership Foundation Trust: "PROVISION OF LONG ACTING REVERSIBLE CONTRACEPTION (LARCS) IN PRIMARY CARE". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityMidlands Partnership Foundation TrustScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Midlands Partnership Foundation Trust
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Midlands Partnership Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
5.6Bids / Report
59.4% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 36 active published awards; 32 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMidlands Partnership Foundation Trust
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published5 Feb 2025, 10:46 GMT
Last source update5 Feb 2025, 10:46 GMT
Recurring procurementNot published
ClassificationGeneral-practitioner services, Health services
Delivery area
West Midlands (UKG2)
OCIDocds-h6vhtk-04dbbf
What is being bought
The Provider will provide governance for the correct fitting, monitoring, checking and removal of contraceptive implants, and IUS and IUDs in line with current guidelines and best practice. It is also expected Practices will work with agencies and establish pathways to refer patients if further support maybe needed. The Provider will also be expected to oversee this.
What changed
From the official release history
  1. Status changed to complete
    5 Feb 2025, 10:46 GMT
  2. Official notice release published
    5 Feb 2025, 10:46 GMT
  3. Buyer information updated
    5 Feb 2025, 10:46 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The Provider will provide governance for the correct fitting, monitoring, checking and removal of contraceptive implants, and IUS and IUDs in line with current guidelines and best practice. It is also expected Practices will work with agencies and establish pathways to refer patients if further support maybe needed. The Provider will also be expected to oversee this.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    5 Feb 2025, 10:46 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 3 Jun 2024, 00:00 BST · £1,837,086
Commercial outcome and competition
Awards
Midlands Partnership University NHS Foundation Trust
Not published · Not published · active
Contracts
PROVISION OF LONG ACTING REVERSIBLE CONTRACEPTION (LARCS) IN PRIMARY CARE
£1,837,086 · signed 3 Jun 2024, 00:00 BST · active
Bid statistics
bids: 86 (lot 1)
Buyer and organisations in this procedure

Midlands Partnership Foundation Trust

Contracting authority GB-FTS-7554
View buyer profile

  • Midlands Partnership Foundation Trust
    buyer

    na
    Trust HQ, Corporation Street,, Stafford, UKG2, ST16 3AG
    bethan.davies@mpft.nhs.uk
    +44 03007907000

  • Midlands Partnership NHS Foundation Trust
    reviewContactPoint

    Trust HQ St Georges Hospital, Corporation Street, Stafford, ST16 3AG
    Procurement@mpft.nhs.uk

  • Midlands Partnership NHS Foundation Trust
    reviewBody

    Trust HQ. St Georges Hospital, Corporation Street, Stafford, ST16 3AG
    Procurement@mpft.nhs.uk

  • Midlands Partnership University NHS Foundation Trust
    mediationBody
    supplier

    Stafford, UKG2
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThis is a Provider Selection Regime (PSR) contract modification notice, under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally modified. This has been awarded under Provider Selection Regime process B. The contract has been awarded to a number of providers who are able to meet the specification, where people are offered a choice between the providers and this is not restricted. To ensure providers meet the specification this has been assessed by clinical and operational colleagues as key decision makers. There are no identified conflicts of interest.